This article outlines the use of liquid acrylic adhesives in the management of congenital vascular malformations. Specifically, the chemical features of cyanoacrylates, including the physical and chemical properties, exovascular use of cyanoacrylates, and the techniques for use of these agents, are discussed.
KEYWORDS
Cyanoacrylates - vascular malformation - congenital disease
REFERENCES
-
1
Kerber C W, Wong W.
Liquid acrylic adhesive agents interventional Neuroradiology.
Neurosurg Clin N Am.
2000;
11
85-99
-
2 Ardis A E. U.S. Patent 2,467,926, 1949.
-
3
Coover Jr H W, Joyner F B, Shearer Jr N H et al..
Chemistry and performance of cyanoacrylate adhesives.
Soc Plast Eng J.
1959;
15
413-417
-
4
Barr J D, Hoffman E J, Davis B R, Edgar K A, Jacobs C R.
Microcatheter adhesion of cyanoacrylates, comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylate.
J Vasc Interv Radiol.
1999;
10
165-168
-
5
The n-BCA trial investigators .
AJNR Am J Neuroradiol.
2002;
23
748-755
-
6
Schweitzer J S, Chang B S, Madsen P et al..
The pathology of arteriovenous malformations of the brain treated by embolotherapy.
Neuroradiology.
1993;
35
468-474
-
7
Toriumi D M, Raslan W F, Friedman M, Tardy M E.
Histotoxicity of cyanoacrylate tissue adhesive: a comparative study.
Arch Otolaryngol Head Neck Surg.
1990;
116
546-550
-
8
Galil K A, Schonfield I D, Wright G Z.
Effect of butyl 2-cyanoacrylate on the healing of skin wounds.
Can Dent Assoc J.
1984;
50
565-569
-
9
Petrella E, Orlandini G, Poisetti P et al..
A new end to side anastomosis formed without sutures for hemodialysis fistulas.
Nephron.
1975;
14
398-400
-
10
O'Leary J A.
Tissue adhesives and pelvic hemostasis: an evaluation of isobutyl 2-cyanoacrylate.
J Surg Oncol.
1971;
3
117-120
-
11
Fogle J A, Kenyon K R, Foster C S.
Tissue adhesive arrests stromal melting in the human cornea.
Am J Ophthalmol.
1980;
89
795-802
-
12
Wilkinson T S, Rybka F J.
Experimental study of prevention of tip necrosis in ischemic z-plasties.
Plast Reconstr Surg.
1971;
47
37-38
-
13
Smyth G DL, Kerr A G.
Histoacryl (butyl cyanoacrylate) as an ossicular adhesive.
J Laryngol Otol.
1974;
88
539-542
-
14
Bhaskar S N, Frisch J, Margetis P M, Leonard F.
Application of a new chemical adhesive in periodontic and oral surgery.
Oral Surg.
1966;
22
526-535
-
15 Bank W O, Kerber C W, Cromwell L D. Rapidly polymerizing glue for the treatment of intracerebral arteriovenous malformations. In: Moss A, Goldberg H Interventional Radiological Techniques: Computed Tomography and Ultrasonography. San Francisco; University of California Press 1981: 83-92
-
16
Cromwell L D, Kerber C W.
Modification of cyanoacrylate for therapeutic embolization: preliminary experience.
AMJ Am J Roentgenol.
1979;
132
799-801
-
17
Spiegel S M, Vinuela F, Goldwasser J M, Fox A J, Pelz D M.
Adjusting the polymerazation of isobutyl-2 cyanoacrylate.
AJNR Am J Neuroradiol.
1986;
7
109-112
-
18
Sadato A, Wakhloo A K, Hopkins L N.
Effect of a mixture of a Low concentration of n-butylcyanoacrylate and Ethiodol on tissue reactions and the permanence of arterial occlusion after embolization.
Neurosurgery.
2000;
47
1197-1203
-
19
Brothers M F, Kaufman J C, Fox A J, Devekis J P.
N-Butyl 2-cyanoacrylate- substitute for IBCA in interventional neuroradiology: histopathological and polymerization time studies.
AJNR Am J Neuroradiol.
1989;
10
777-786
-
20
White Jr R I, Strandberg J V, Gross G S, Barth K H.
Therapeutic embolization with long term occluding agents and their effects on embolized tissues.
Radiology.
1977;
125
677-687
-
21
Vinters H V, Galil K A, Lundie M J, Kaufman J C.
The histotoxicity of cyanoacrylates: a selective review.
Neuroradiology.
1985;
27
279-291
-
22
Wikholm G.
Occlusion of cerebral arteriovenous malformations with N-butyl cyano-acrylate is permanent.
AJNR Am J Neuroradiol.
1995;
16
479-482
-
23
Gruber A, Mazal P R, Bavinski G, Killer M, Budka H, Richling B.
Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study.
AJNR Am J Neuroradiol.
1996;
17
1323-1331
-
24
Rao V R, Mandalam K R, Gupta A K, Kumar S, Joseph S.
Dissolution of isobutyl 2-cyanoacrylate on long term follow up.
AJNR Am J Neuroradiol.
1989;
10
135-141
-
25 Brown L C, Mellick P W, Smith C D et al.. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate (IBC) in fischer-344 rats. NTIS/AD-A222 000/2, 1990.
-
26 Brown L C, Mellick P W, Smith C D et al.. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate in fischer-344 rats. Report: ISS LAIR-433, Toxicology ser-187, Order No. AD-A22 2000 1990: 1161
-
27 Brown L C, Smith C D, Lollini L O et al.. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report, Vol. 1. NTIS/AD-A195 913/9 1988
-
28 Brown L C, Smith C D, Lollini L O et al.. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report, Vol. 2, part 1. NTIS/AD-A201 448/8 1989
-
29 Brown L C, Smith C D, Lollini L O et al.. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report. Vol. 2, part 2. NTIS/AD-A197 679/4 1988
-
30
Debrun G M, Aletich V, Ausman J I, Charbel F, Dujovny M.
Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate.
Neurosurgery.
1997;
40
112-120
-
31
Kunstlinger F, Brunelle F, Chaumont P, Doyon D.
Vascular occlusive agents.
AJR Am J Roentgenol.
1981;
136
151-156
Robert J RosenM.D.
Division of Interventional Radiology and Endovascular Surgery
New York University Medical Center, New York, NY
eMail: Robert.rosen@med.nyu.edu
